PBM Reforms—Are Sweeping Changes in Store for a Much-Maligned Industry?

David Ostrowsky analyzes growing bipartisan momentum behind PBM reform as lawmakers respond to concerns over rising drug costs and opaque PBM practices. He highlights proposed changes such as banning spread pricing, increasing transparency in Medicare Part D and employer plans, and restructuring PBM compensation, noting that these efforts could significantly reshape the pharmacy benefits landscape for employers, health plans, and patients.